Biosensis Pty Ltd

Biosensis specializes in antibodies and reagents for Neuroscience. Our neuroscience portfolio includes products for research in neurodegenerative diseases, neurodevelopment,and neuro-metabolism. Areas of focus include Alzheimers, Parkinsons and ALS diseases, as well as autophagy and metabolic and stress disorders including metabolic syndrome research, obesity, and neuroimmunology and inflammation with particular emphasis on neurotrophins and neurotrophin receptors for which Biosensis has been the worldwide leader and OEM supplier for more than 30 years. Biosensis also offers more than 200 high-quality ELISA kits for a wide range of protein targets. Our assays are validated for a variety of sample matrices and where possible,...

Antibodies,elisa kits,proteins,molecule inhibitors,peptides,monoclonal antibody,staining kit,neurology,neuroscience,western blot reagents,immunohistochemistry,cell culture,alzheimer's disease,parkinson's disease,speciality buffers,cancer research,stem cell research,immunoassays,immunotoxins,and autophagy

Biosensis pty ltd operates in the Biotechnology research industry.

Biosensis pty ltd's revenue is 11m - 100m

Biosensis pty ltd has 11 - 50 employees.